The prevalence of bcl-2, p53, and ki-67 immunoreactivity in transitional cell bladder carcinomas and their clinicopathologic correlates

Mutations in the p53 tumor suppressor gene: clues to cancer etiology and molecular pathogenesis.

Marc S. Greenblatt, W P Bennett, Monica Hollstein et al. · PubMed · 1994 · 3.5K citations

Medicine, Genetics, Molecular Genetics +16

Bcl-2 gene promotes haemopoietic cell survival and cooperates with c-myc to immortalize pre-B cells

David L. Vaux, Suzanne Cory, Jerry M. Adams · Nature · 1988 · 3.2K citations

Life Sciences, Cell Biology, Molecular Biology +12

Tumor suppressor p53 is a regulator of bcl-2 and bax gene expression in vitro and in vivo.

Toshiyuki Miyashita, Stanisław Krajewski, Maryla Krajewska et al. · PubMed · 1994 · 2.2K citations

Life Sciences, Cell Biology, Oncology +13

Wild-type p53 induces apoptosis of myeloid leukaemic cells that is inhibited by interleukin-6

Elisheva Yonish-Rouach, Dalia Resnftzky, Joseph Lotem et al. · Nature · 1991 · 2.1K citations

Medicine, Hematology, Oncology +13

Involvement of the <i>bcl</i> -2 Gene in Human Follicular Lymphoma

Yoshihide Tsujimoto, Jeffrey Cossman, Elaine S. Jaffe et al. · Science · 1985 · 1.8K citations

Life Sciences, Genetics, Molecular Genetics +16